Purchase Order HHSN275201600037P

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $19,210 purchase order to Horizon Genomics GMBH for "OTHER FUNCTIONS - HAP 1 KNOCKOUT CELLS & HAP1 CELLS." Horizon Genomics GMBH, a subsidiary of Haplogen GMBH, will deliver the requested HAP1 knockout and HAP1 cells under a firm fixed price contract with performance taking place in Bethesda, Maryland over a three-month period concluding in...

This purchase order, awarded by the National Institutes of Health's National Institute of Child Health and Human Development, is for one unit of HAPLOGEN HAP1DEPDC52039600 CRISPR/CAS9-EDITED DEPDC5 for $1,105.90, with a total contract value of $5,728.50. The prime contractor, Government Scientific Source Inc. doing business as G S S, will deliver the product from its place of performance in Herndon, Virginia between September 11, 2014 and October 31, 2014 under firm fixed pricing. No set aside...

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...

This is a $24,940 firm-fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to Psomagen Inc., a genomics and molecular biology services company, to provide products for proteomic analysis on sickle cell plasma as part of ongoing sickle cell research efforts. The contract has an ultimate completion date of December 5, 2025. Psomagen Inc. is a subsidiary of Macrogen, Inc. and a for-profit manufacturer of goods that...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $202,000.00 firm fixed price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for the "SIRNAS WITH ACCELL MODIFICATION PROJECT". The contract, which does not have a small business set-aside, is for the provision of various gene silencing and regulation products, including small interfering...

This is a $24,940 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer and genomics/molecular biology services company, for Olink proteomic assays to support the Laboratory of Sickle Cell Genetics and Pathophysiology's research on the relationship between the TTR V122I genetic mutation and its protein variant. The award is not associated with a set-aside program and has an ultimate...

The National Institute of Child Health and Human Development (NICHD) awarded a $43,072.70 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED for custom CRISPR activation (CRISPRa) and CRISPR knockout (CRISPRko) synthetic single guide RNA (sgRNA) pool libraries. The award, issued on September 10, 2025, with a completion date of September 30, 2025, provides genome-wide functional genomic screening libraries to support research identifying novel phosphate transporters. The...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to SB Drug Discovery LIMITED, a for-profit organization, to provide cultured cells stably expressing the human form of the NAV1.5 channel protein for use in in vitro electrophysiology and ion channel pharmacology projects. The contract has a ceiling value of $24,000.00 and was awarded on June 28, 2016 with a completion date of September 24, 2016. The award was not associated with any...

Horizon Discovery Biosciences LIMITED has been awarded a firm fixed price purchase order totaling one hundred twenty-one thousand two hundred ninety-four dollars and sixty-four cents ($121,294.64) by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to supply a Dharmacon Human On-TargetPlus Druggable Genome siRNA Library for the Functional Genomic Lab. The purchase order does not include any set-aside designations...

This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business, for a firm-fixed-price purchase order in the amount of $63,000.00. The contract calls for the use of CRISPR gene editing technology to create two custom induced pluripotent stem cell (iPSC) reporter cell lines - one with dual gene knock-ins for albumin and alpha-fetoprotein, and...